miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- PMID: 22101765
- DOI: 10.1038/nm.2512
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Abstract
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
Comment in
-
Stressed tumor cell, chemosensitized cancer.Nat Med. 2011 Dec 6;17(12):1552-4. doi: 10.1038/nm.2593. Nat Med. 2011. PMID: 22146456 No abstract available.
Similar articles
-
The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.Curr Pharm Des. 2014;20(11):1888-95. doi: 10.2174/13816128113199990523. Curr Pharm Des. 2014. PMID: 23888941
-
Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2392-401. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966949 Free PMC article.
-
miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.Oncotarget. 2016 Dec 6;7(49):81621-81633. doi: 10.18632/oncotarget.13154. Oncotarget. 2016. PMID: 27835595 Free PMC article. Review.
-
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.Clin Transl Oncol. 2015 Oct;17(10):779-87. doi: 10.1007/s12094-015-1303-1. Epub 2015 Jun 11. Clin Transl Oncol. 2015. PMID: 26063644
-
The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.Int J Mol Sci. 2015 Jul 24;16(8):16833-47. doi: 10.3390/ijms160816833. Int J Mol Sci. 2015. PMID: 26213923 Free PMC article. Review.
Cited by
-
Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer.Front Genet. 2020 Jul 17;11:705. doi: 10.3389/fgene.2020.00705. eCollection 2020. Front Genet. 2020. PMID: 32765584 Free PMC article.
-
MiRNA-429 suppresses the growth of gastric cancer cells in vitro.J Biomed Res. 2012 Sep;26(5):389-93. doi: 10.7555/JBR.26.20120029. Epub 2012 Sep 20. J Biomed Res. 2012. PMID: 23554776 Free PMC article.
-
Stressed tumor cell, chemosensitized cancer.Nat Med. 2011 Dec 6;17(12):1552-4. doi: 10.1038/nm.2593. Nat Med. 2011. PMID: 22146456 No abstract available.
-
p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death.Cell Cycle. 2015;14(10):1548-58. doi: 10.1080/15384101.2015.1026491. Cell Cycle. 2015. Retraction in: Cell Cycle. 2022 Dec;21(23):2559. doi: 10.1080/15384101.2022.2113232. PMID: 25789565 Free PMC article. Retracted.
-
MicroRNA Therapeutics in Cancer: Current Advances and Challenges.Cancers (Basel). 2021 May 29;13(11):2680. doi: 10.3390/cancers13112680. Cancers (Basel). 2021. PMID: 34072348 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases